The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Correvio Pharma Corp. common stock – CORV

January 10, 2021

If you purchased Blue Apron Holdings, Inc. (“Blue Apron”) Class A Common Stock during the period from June 29, 2017, through August 25, 2017, both dates inclusive (“Settlement Class Period”), your rights may be affected by this Settlement, including the release and extinguishment of claims you may possess relating to your ownership interest in Blue Apron Class A Common Stock. If you have not received a detailed Notice of Pendency and Proposed Settlement of Class Action (“Notice”) and a copy of the Proof of Claim and Release Form

Click here to learn more about The Rosen Law Firm’s representation of investors in securities litigation: for pension funds, foundations, endowments, family offices, hedge funds, individuals.

While selective about commencing litigation, we are committed to expanding relevant laws for the benefit of shareholders. We undertake in-depth analysis of potential claims and damages before recommending that our clients initiate litigation or seek to become lead plaintiff in a case. Click here to find out more.

If you have heard about a suit being filed regarding one of the companies in your portfolio, click here.

Receive “Letter of The Law,” our regular newsletter on securities litigation affecting institutional and individual investors.

“Letter Of The Law” Newsletter sponsored by: The Rosen Law Firm, 275 Madison Avenue, 40th Floor. New York, New York, 10016

Galena Biopharma: A Twist on The Classic “Pump & Dump”

So here we had a situation where Plaintiffs and the

Fiat Chrysler Cheats Emissions Tests & Investors

The Rosen Law Firm recovered millions for investors who purchased

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Correvio Pharma Corp. common stock – CORV

If you purchased Blue Apron Holdings, Inc. (“Blue Apron”) Class